Aryeh Batt is the co-founder and CEO of Precise Bio, where he leads the development of advanced bio-fabrication technologies aimed at transforming tissue and organ replacement. With a background spanning engineering, biomedical innovation, and translational research, he has overseen the creation of the company’s 4D bioprinting platform and its first clinical programs in ophthalmology. Under his leadership, Precise Bio has progressed from early-stage tissue engineering concepts to pioneering lab-grown, 3D-printed corneal implants now being tested in human trials, reflecting his focus on scalable, clinically impactful solutions in regenerative medicine.